Facile green synthesis of baicalein fabricated gold nanoparticles and their antibiofilm activity against Pseudomonas aeruginosa PAO1
0301 basic medicine
Drug Carriers
Plant Extracts
Polysaccharides, Bacterial
Metal Nanoparticles
Biocompatible Materials
Green Chemistry Technology
Microbial Sensitivity Tests
Gold Compounds
Anti-Bacterial Agents
03 medical and health sciences
Chlorides
Microscopy, Electron, Transmission
X-Ray Diffraction
Biofilms
Flavanones
Pseudomonas aeruginosa
Spectroscopy, Fourier Transform Infrared
Microscopy, Electron, Scanning
Spectrophotometry, Ultraviolet
DOI:
10.1016/j.micpath.2017.03.044
Publication Date:
2017-04-01T22:16:24Z
AUTHORS (4)
ABSTRACT
Biofilm formation is one of the major problems associated with chronic diseases and also attributes for the antibiotic resistance in bacteria. In recent times nanoparticles have been utilized to improve the efficacy of the existing antimicrobial and anti-biofilm agents. The ease in functionalization of gold nanoparticles (AuNPs) makes them a potential carrier for antimicrobial agents. However, the use of physical or chemical methods of the production of nanoparticles is expensive, labour intensive and hazardous to ecosystem. On the other hand, the use of plant based compounds serve as an eco-friendly way for the synthesis of nanoparticles with improved biocompatibility and therapeutic applicability. In the present study, phytocompound, baicalein was used as a reducing and capping agent for the synthesis of spherical shape AuNPs. The baicalein decorated gold nanoparticles (BCL-AuNPs) were characterized and evaluated for their anti-biofilm efficacy against Pseudomonas aeruginosa PAO1. The biosynthesized BCL-AuNPs was characterized using UV-Visible spectra, Dynamic Light Scattering (DLS), Fourier transform infrared (FTIR) spectroscopy, Scanning Electron Microscopy (SEM), Energy Dispersive X-ray Diffraction (EDAX), and High Resolution Transmission Electron Microscopy (HR-TEM). The biosynthesized BCL-AuNPs were determined to be spherical in shape with an average size of 26.5 nm. The sub-MIC concentration of BCL-AuNPs exhibited significant anti-biofilm activity against P. aeruginosa PAO1. On treatment with BCL-AuNPs (100 g mL-1), a reduction in biofilm formation by 58.74 ± 5.8% and 76.51 ± 4.27% was observed in microtiter plate assay and tube method, respectively. A significant reduction in exopolysaccharide (EPS) production by 81.29± 2.96% was observed. The swimming and swarming motility were also effectively arrested in presence of BCL-AuNPs. Further, Light microscope and CLSM studies were carried out to examine the effect of BCL-AuNPs on the surface topography and architecture of P. aeruginosa biofilm. Thus, the present study suggests the potential use of BCL-AuNPs in the development of novel therapeutics for the prevention and treatment of biofilm associated chronic infections.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (25)
CITATIONS (76)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....